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ABSTRACT
Background: Flowcytometric analysis of purified eosin-
ophils requires several hours to accomplish due mainly
to purification of cells; moreover, it requires more than
20 mL blood and expensive reagents. The aim of the
present study was to develop a method of direct flow-
cytometric analysis for eosinophils using whole blood.
Methods: Peripheral blood obtained from five healthy
individuals (mean age 42 years) and 10 patients with
eosinophilia (mean age 40.3 years) were used for
analysis. We stained antigens (CD9 or CD16) and fixed
cells with parabenzoquinone (PBQ) or paraformalde-
hyde (PFA) after hemolyzation followed by treatment
with N-octyl-β-glucopyranoside (OG).
Results: On comparison of forward scatter with side
scatter dot plots among samples treated with hemolyza-
tion alone, PBQ fixation and PFA fixation, PBQ fixation
showed the best results in discriminating eosinophils
from other leukocyte fractions on the cytogram. Follow-
ing fixation and permeabilization of cells, EG2, a
secretory form of eosinophil cationic protein, was
stained as an intracellular antigen. Flowcytometric
analysis for EG2 showed a high positivity rate only 
in the eosinophil fraction. There were no differences 
in EG2 positivity or mean fluorescence intensity 
(MFI) between heparinized and EDTA-treated blood.
Comparison of samples treated with OG at 6.0 and
7.4 mg/mL showed that the latter had a higher MFI for
EG2 without significant change in the positivity rate.
Conclusions: The findings show that intra- and extra-
cellular properties of eosinophils can be analyzed with
whole blood using PBQ fixation and OG treatment at
a concentration of 7.4 mg/mL. Direct flowcytometric
analysis of eosinophils saves time and requires only a
small amount of blood, both of which are advanta-
geous for patients and laboratory workers.
Key words: EG2, eosinophils, flow cytometry, whole
blood.
INTRODUCTION
In allergic inflammatory diseases, eosinophils are thought
to play an important role as the main effector cells.
Changes in surface or intracellular expression of anti-
gens related to eosinophils are attracting special interest
because of their expected clinical importance as indica-
tors of pathological conditions in allergic inflammatory
diseases. So far, purified eosinophils have been mainly
used for analysis of eosinophils.1 Eosinophils are purified
by negative depletion of CD3, CD14, CD16 and CD20,2
using the magnetic bead method with high purity at good
yields;3 however, time and skill are required to obtain
eosinophils maintaining in vivo functions. The conven-
tional method for analysis using purified eosinophils 
is not likely to be widely accepted by routine clinical
laboratories because of the time involved, the expense
and the amount of blood required for purification of
eosinophils. Recently, Hollden et al.4 reported a FOG
method in which cells are fixed with paraformaldehyde
(PFA) after hemolyzation of whole blood followed by 
Allergology International (2001) 50: 319–324
Original Article
Direct flowcytometric analysis of eosinophils using a
whole blood staining technique
Yumiko Kamada,1 Akira Tsuda,2 Hiroyuki Kayaba,1 Osamu Urayama,2
Hajime Oyamada,1 Tomoe Kuwasaki,1 Kiumi Takasaki,1 Norihiro Saito2 and
Junichi Chihara2
1Central Clinical Laboratory and 2Department of Clinical Laboratory Medicine, Akita University 
School of Medicine, Akita, Japan
Correspondence: Dr Junichi Chihara, Department of Clinical
and Laboratory Medicine, Akita University School of Medicine,
1-1-1 Hondo, Akita 010-8543, Japan. 
Email: chihara@hos.akita-u.ac.jp
Received 18 September 2000. Accepted for publication 
25 June 2001.
320 Y KAMADA ET AL.
N-octyl-β-gluopyranoside (OG) treatment to increase
membrane permeability for the staining of intracellular
antigens. Krug et al.5 detected intracellular granular
proteins of eosinophils using parabenzoquinone (PBQ)
instead of PFA. Based on these reports and with an aim to
develop a simple method for flowcytometric analysis of
surface and intracellular expression of various molecules,
such as adhesion molecules, chemokine receptors and
granular proteins of eosinophils, in a routine clinical
laboratory, techniques for whole blood flowcytometric
analysis of eosinophils were evaluated. First, the purity of
eosinophils gated on the cytogram in whole blood flow-
cytometry was determined by staining surface markers of
eosinophils (CD16 negative, CD9 positive). Then, using
an EG2 monoclonal antibody,6 a secretory type of eosin-
ophil cationic protein (ECP) expressed intracellularly by
eosinophils, EG2 was also detected and investigated to
determine whether intracellular antigens can be evalu-
ated as well as surface antigens using the whole blood
flowcytometry technique.
METHODS
There were 15 participants in the present study, compri-
sing five healthy individuals (age range 37–51 years;
mean age 42 years) and 10 patients with eosinophilia,
including four patients with eosinophilic pneumonia (age
range 45–65 years; mean age 42 years), three patients
with bronchial asthma (age range 23–56 years; mean
age 40 years) and three patients with atopic dermatitis
(age range 18–26 years; mean age 22 years). Eosino-
philia was defined as more than 700 eosinophils/µL in
peripheral blood.
Surface staining for whole blood flowcytometry
For the identification of eosinophils, 10 µL phyco-
erytherin (PE)-labeled anti-CD9 monoclonal antibody
(clone M-L13; Pharmingen, San Diego, CA, USA) or 
PE (or fluorescein isothiocyanate (FITC) in double color
staining)-labeled anti-CD16 monoclonal antibody (clone
3G8; Pharmingen) was added to 100 µL heparinized or
EDTA-treated blood and incubated. Unless otherwise
mentioned, the incubation was performed at 4°C for 
30 min. Then, 2 mL lysing solution (Beckton Dickinson,
Franklin Lakes, NJ, USA) was added and incubated for 
10 min at room temperature in the dark for hemo-
lyzation. After centrifugation at 300 g for 5 min, the
supernatant was removed and 100 µL of 0.4% PBQ
(Wako Pure Chemicals, Tokyo, Japan) or 4% PFA (Wako
Pure Chemicals) was added to the remaining cells and
the mixture was kept at room temperature in the dark 
for 10 min to fix the cells. After washing once with
phosphate-buffered saline (PBS), cells were reacted with 
100 µL OG (Wako Pure Chemicals) at two final concen-
trations of 6.0 or 7.4 mg/mL to increase membrane
permeability. After incubation for 5 min at room tempera-
ture in the dark, cells were washed twice with PBS and
resuspended in 400 µL PBS for flowcytometric analysis.
For the detection of various proteins other than CD9
and CD16 expressed on the surface of eosinophils,
monoclonal antibodies against the proteins targeted by
the study were used. Fluorescein isothiocyanate- or PE-
labeled secondary antibodies were used when non-labeled
primary antibodies were used. After incubation with the
antibodies, cells were treated with lysing solution, PBQ
and OG (7.4 mg/mL) in the same manner as described
above. As an example of the surface staining of eosin-
ophils in whole blood, the expression of Mac-1 on
eosinophils is shown in the Results section.
Intracellular staining for whole blood 
flowcytometry
After treatment with lysing solution, PBQ and OG as
described above, 5 µL EG2 monoclonal antibody (Cabi-
Pharmacia, Uppsala, Sweden) or irrelevant mouse IgG1
(DAKO, Kyoto, Japan) as an isotype control was added
and incubated. After washing once with PBS, 100 µL 
of 100-fold diluted FITC-conjugated goat antimouse
Immunoglobulins (Biosource International, Camarillo,
CA, USA) was added to the reaction mixture and incu-
bated. Then, cells were washed once with PBS and
resuspended in 500 µL PBS for flowcytometry.
Flowcytometric analysis
More than 15 000 cells were counted for flowcytometric
analysis by Facscan with LYSIS II software (Becton
Dickinson). The positivity rate for the control was adjusted
to less than 1%. The change in mean fluorescence
intensity (∆MFI), which was obtained by subtracting the
control MFI from that of the sample, was used as an index
of expression level. Because eosinophils have stronger
spontaneous fluorescence than other leukocytes, adjust-
ment of compensation levels was carefully performed
between FL1 (FITC) and FL2 (PE) to avoid leakage of FITC
and PE fluorescence into the detectors when cells were
stained with double color. For the purpose of confirming
the constant condition of the cell analyzing system, Calib
RATE beads (Becton Dickinson) were used for each
measurement. Reproducibility of photomultiplier (PMT)
voltage, adjustment for fluorescent dyes and detection
sensitivity under the operating conditions were confirmed
at each measurement.
Statistical analysis
All values are presented as the mean±SD. For analysis 
of the significance of differences between two groups,
Student’s t-test was used. In comparisons of three or
more groups, Fisher’s protected least significant differ-
ence (PLSD) method was used as a post hoc test,
regarding P < 0.05 as significant after analysis of
variance.
RESULTS
Comparison of cytograms of samples treated with
hemolyzation alone, 4% PFA and OG or 0.4% PBQ and
OG is shown in Fig. 1. In Fig. 1, the x and y axes repre-
sent the forward light scattering and side light scattering
at 90°, respectively. By hemolyzation alone, neutrophil
and eosinophil fractions overlapped each other and
gating for eosinophils was difficult due to the unclear
boundary. The boundary became clear after PFA and OG
treatment; however, there was still a narrow overlapping
area. Of the procedures tested, PBQ and OG treatment
yielded the best cytogram for the gating of eosinophils
(Fig. 1). The CD9-positivity rate in the gated area 
representing the eosinophil fraction was 91.9 ± 3.8,
93.5 ± 2.15 and 95.4 ± 1.7% in samples treated with
hemolyzation alone, PFA + OG and PBQ + OG, res-
pectively (Fig. 2). Samples treated with PBQ and OG
showed a lower CD16 positivity rate (6.9 ± 1.9%) in the
gated area than samples treated with hemolyzation alone
(19.2 ± 5.6%; P < 0.05) or PFA fixation (9.6 ± 3.1%;
NS; Fig. 3). Based on these results, the intracellular
EG2-positivity rate and MFI were evaluated in samples
obtained from patients with eosinophilia after PBQ and
OG treatment. Blood was sampled with two sample
tubes, one containing heparin and the other containing
EDTA as an anticoagulant. As in the reports of Hallden 
et al.,4,7 two different concentrations of OG (6.0 and 
7.4 mg/mL) were used in the preparation of blood
samples for comparison in the present study. The eosino-
phils showed a high positivity rate for EG2 regardless of
the anticoagulants or OG concentrations (Fig. 4). Com-
parison of samples treated with OG at concentrations of
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Fig. 1 Changes in cytograms of leukocyte fractions in whole
blood after treatments. (c) The cytogram of peripheral whole
blood treated with parabenzoquinone and N-octyl-β-glucopy-
ranoside (OG) showed highly selective acquisition of
eosinophils compared with other cytograms treated with
paraformaldehyde and OG (b) or without treatment (a).
either 6.0 or 7.4 mg/mL, the latter had a significantly
higher MFI for EG2 than the former, regardless of the
anticoagulant (Fig. 5). The positivity rates for EG2 in
heparinized blood samples fixed with PBQ and per-
meabilized by OG at concentrations of 6.0 and 7.4 mg/mL
were 88.0 ± 3.2 and 88.9 ± 4.8%, respectively. Samples
treated with EDTA showed a positivity rate of 88.3 ± 3.4
and 86.9 ± 8.3% at OG concentrations of 6.0 and
7.4 mg/mL, respectively. The MFI for EG2 in heparinized
blood samples fixed with PBQ and permeabilized by
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Fig. 2 CD9-positivity rate in the eosinophil gating field. The
CD9-positivity rate was 91.9 ± 3.8, 93.5 ± 2.15 and 95.4
± 1.7% in samples treated with hemolyzation alone (,
paraformaldehyde + N-octyl-β-glucopyranoside (OG; ) and
parabenzoquinone + OG ( ), respectively.
Fig. 3 CD16-positivity rate in eosinophil gating field. The
sample treated with parabenzoquinone and N-octyl-β-
glucopyranoside (OG; ) showed a lower CD16 positivity rate
(6.9 ± 1.9%) in the gated area than samples treated with
hemolyzation alone (; 19.2 ± 5.6%; P < 0.05) or para-
formaldehyde fixation (; 9.6 ± 3.1%; NS).
Fig. 4 The EG2 positivity rate in the eosinophil gating field.
Eosinophil fractions of allergic patients were gated and exam-
ined for intracellular EG2-positivity rate using para-
benzoquinone (PBQ) fixation. The eosinophils showed a high
positivity rate for EG2 regardless of the anticoagulants or 
N-octyl-β-glucopyranoside (OG) concentrations used. The
positivity rates for EG2 in the heparinized blood samples fixed
with PBQ and permeabilized by OG at concentrations of 6.0
( and 7.4 mg/mL ( ) were 88.0 ± 3.2 and 88.9 ± 4.8%,
respectively. Samples treated with EDTA showed a positivity rate
of 88.3 ± 3.4 and 86.9 ± 8.3% at OG concentrations of 6.0
() and 7.4 mg/mL ( ), respectively.
Fig. 5 Mean fluorescence intensity (MFI) for EG2 in the
eosinophil gating field. Comparison of samples treated with N-
octyl-β-glucopyranoside (OG) at 6.0 and 7.4 mg/mL showed
that the latter had a significantly higher MFI for EG2 than the
former, regardless of the anticoagulant. The MFI for EG2 in
heparinized blood samples fixed with parabenzoquinone (PBQ)
and permeabilized by OG at concentrations of 6.0 () and 
7.4 mg/mL ( ) was 625.2 ± 72.3 and 1023.1 ± 325.8 FI,
respectively. Samples treated with EDTA showed an MFI of
475.2 ± 101.6 and 960.2 ± 264.3 FI at OG concentrations
of 6.0 () and 7.4 mg/mL ( ), respectively.
OG at concentrations of 6.0 and 7.4 mg/mL were
625.2 ± 72.3 and 1023.1 ± 325.8 FI, respectively.
Samples treated with EDTA showed a MFI of 475.2 ±
101.6 and 960.2 ± 264.3 FI at OG concentrations of
6.0 and 7.4 mg/mL, respectively.
An example of whole blood flowcytometric analysis on
the surface expression of Mac-1 on eosinophils is shown
in Fig. 6. An increase in Mac-1 expression in a patient
with eosinophilia compared with that of a normal subject
was demonstrated.
DISCUSSION
Although various methods for the flowcytometric detec-
tion of eosinophils in whole blood using the eosinophil
property of strong spontaneous fluorescence have been
investigated,8,9 these methods are not generally used
because of the fact that the fluorescence of neutrophils
increases in some pathological conditions.10 By staining
cell surface CD9 and CD16 in whole blood and hemo-
lyzing, followed by treatment with PBQ and OG, the
eosinophil fraction (CD9 positive, CD16 negative) was
more easily gated on the cytogram separately from other
leukocyte fractions. In the gated area, CD9 was positive
in 95.4 ± 1.7% of cells and CD16, representing neu-
trophil contamination, was positive in 6.9 ± 1.9% of
cells, which was a good result. The fact that the cytogram,
with an unclear boundary between eosinophils and neu-
trophils, has a high CD16 positivity rate may suggest that
the neutrophils (CD16 positive) are the main contamin-
ating cells of the eosinophil fraction.
The major component of the lysing solution used in
the present study was 5.0% diethyleneglycol and 1.5%
formaldehyde, and formaldehyde may fix the cells at
hemolyzation to some extent. Carulli et al.9 reported that
a cytogram of the eosinophil fraction could be obtained
by treatment with lysing solution alone and the percent-
age of eosinophils in the gated area showed a good
correlation with the results obtained by an automatic
blood cell counter. However, in the present study, when
whole blood was treated with lysing solution alone, the
eosinophil fraction and neutrophil fraction overlapped
each other, making the gating of the eosinophil fraction
difficult. On gating a high granularity area of the leuko-
cyte fraction in the sample treated with lysing solution
alone, 19.2% of gated cells were CD16 positive, show-
ing contamination by neutrophils. Using a hypotonic salt
solution as a hemolytic agent, the eosinophils lessened
their homogeneity on their size and granularity, resulting
in a scattered forward scatter compared with side scatter
dot plot and unclear boundaries between other leukocyte
fractions (data not shown). Krug et al.5 compared PBQ
and PFA fixation and noted that non-specific binding of
FITC occurred in samples fixed by PFA, whereas clear
separation of the eosinophil fraction from other leukocyte
fractions was obtained by PBQ fixation. Although we did
not confirm non-specific binding of FITC in samples fixed
with PFA, we did obtain consistent results in that the
eosinophil fraction was clearly gated using PBQ fixation.
N-Octyl-β-glucopyranoside, which was used to increase
membrane permeability, is a non-ionic surfactant, and
the critical micelle concentration is reported to be
0.74%.4 Hallden et al.7 stained cytoplasmic antigens in
lymphocytes with antivimentin and determined that the
optimal OG concentration lies within a range from 
6.0 to 8.0 mg/mL. Later, in 1993, Hallden and Hed4
reported the FOG method, which is a method of staining
eosinophil intracellular granular protein, setting the OG
concentration to 0.74%. In the present study, intracellular
staining was performed at two different OG concentrations
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Fig. 6 Expression of Mac-1 on eosinophils. An example of
whole blood flowcytometric analysis on the surface expression
of Mac-1 on eosinophils is shown as histograms obtained from
a patient with eosinophilia () and a normal subject (). An
increase in Mac-1 expression was demonstrated in the patient
with eosinophilia compared with the normal subject.
(6.0 and 7.4 mg/mL). As a result, the EG2-positivity rate
did not differ significantly between the two OG con-
centrations, but MFI was higher in cells treated with 
7.4 mg/mL of OG, representing increased cell mem-
brane permeability. Furthermore, although the data are
not shown, the MFI for EG2 was significantly higher in
asthmatic patients than in healthy individuals. The signifi-
cance of the difference in MFI between asthmatic patients
and healthy individuals was greater in samples per-
meabilized using OG at 7.4 mg/mL than in samples
permeabilized using OG at 6.0 mg/mL,11 indicating that
7.4 mg/mL OG is appropriate for EG2 measurements.
In the present study, heparin and EDTA were used as anti-
coagulants. Because there was no significant difference
in either the EG2-positivity rate or MFI between heparin-
ized and EDTA-treated blood, when measurement of
intracellular EG2 antigens is incorporated into a routine
test as an index of activated eosinophils,12,13 an appropri-
ate anticoagulant for individual patients can be selected.
Sano et al.14 reported a method for whole blood flow-
cytometric analysis of eosinophils using a double-staining
technique, which distinguishes very late antigen (VLA)-
4-positive eosinophils from VLA-4-negative neutrophils.14
Compared with the method of Sano et al., our method
has some advantages, as described below. First, our
method does not require an expensive antibody only for
the detection of eosinophils. Second, in the method of
Sano et al., one must be aware of the existence of anti-
VLA-4 antibody bound to VLA-4 on the eosinophils when
selecting a secondary antibody to detect the other pro-
teins to be evaluated. Third, the method of Sano et al.
requires calibration for double staining even if the evalu-
ation could be performed with single-color staining by
our method.
Our method allows intra- and extracellular analysis
of eosinophil properties using whole blood without an
eosinophil separation procedure that consumes several
hours. Moreover, only 100 µL blood is required for each
sample tube using our method, which is a great advant-
age, especially for pediatric patients. This method brings
us one step closer to finding a simple, non-time consum-
ing test for the evaluation of allergic diseases through
eosinophils.
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